Human immunology has advanced at a breakneck pace in recent years, and additional breakthroughs are expected in the near future. Although the immune system is incredibly complex, new tools and abilities are being developed to study it. The discovery of thousands of distinct monoclonal antibodies that allow the identification of a wide variety of cell subpopulations and the functional study of immune cells is one of the most important reasons in these breakthroughs. In various disorders, research into the interplay of the immune system with other systems, such as the neurological and endocrine systems, or the microbiome, has yielded intriguing insights with substantial clinical implications. All of these advancements can be used to a variety of immune-mediated diseases, but the recent success of several immunotherapies is revealing new approaches to study and influence the immune system for our benefit. The treatment of disease by activating or suppressing the immune system is known as immunotherapy or biological therapy. Immunotherapies that elicit or magnify an immunological response are called activation immunotherapies, while those that diminish or suppress the immune response are called suppression immunotherapies.
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, University of London, United Kingdom
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Innovative educational strategies in tissue engineering: Integrating research into higher education
Laurie Mans, University of Applied Biosciences Leiden, Netherlands
Title : Keratin-TMAO wound dressing promote tissue recovery in diabetic rats via activation of M2 macrophages
Marek Konop, Medical University of Warsaw, Poland